AGENDA

Cancer Survivorship Program

Linda Jacobs, PhD, CRNP, FAAN

Microhematuria Guidelines: An Update

Jay D. Raman, MD

Industry Partner Introductions

Stone Management: Dietary Approaches

Necole Streeper, MD

Women’s Pelvic Health

Diane Newman, DNP, FAAN, BCB-PMD

Urodynamics – Interpretation and Implementation

Mikel Gray, PhD

Genetics and Genitourinary Malignancies

Leonard Gomella, MD

Health Policy in Urology and APPs: Where We Are and What Is On the Horizon

Michel Pontari, MD

Bladder Cancer – Management with Updates on Chemo/Immunotherapeutic Agents

Max Kates, MD

Decipher and Biomarkers in Prostate Cancer

Edouard Trabulsi, MD, FACS
Thomas Jefferson University
Sponsored by Decipher Biosciences

Impact of Late LHRH Agonist Dosing on Testosterone Suppression
and Relevance of 6-month Dosing in Current Pandemic Environment and Beyond

Stuart Atkinson, MB, ChB
VP, Head of Medical Affairs, Tolmar Pharmaceuticals Inc.
Sponsored by Tolmar

The Early Detection of Clinically Significant Prostate Cancer Discussion

Ericka M Bagi, BSN, RN
Medical Liaison, MDxHealth
Sponsored by MDxHealth